Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your prescriber has asked you to administer a half dose of Mounjaro, the clicks on the KwikPen are the mechanism you need to understand. Each full dose requires two clicks — one to prime the dose counter and one to inject — and a half dose means stopping after a single click. That answer is short; the safe practice around it is not. Mounjaro (tirzepatide) is a prescription-only medicine, and any change to your dosing (including splitting a dose) must be directed by the prescriber who assessed you, not something to improvise. The NHS medicines page for tirzepatide and your pen's Patient Information Leaflet are the authoritative references for injection technique; what follows is educational context for patients who have already been given that clinical direction.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the moment: you have prepped your injection site, the KwikPen is out of its tray, and you are not entirely sure whether you stop at the first click or keep going. A question our prescribers hear most weeks is some version of exactly this. The Mounjaro KwikPen is designed around a two-click injection cycle. The first click signals that the dose counter has reached the halfway point of its travel; the second click signals that the full dose has been delivered. When a prescriber directs a half dose, the instruction is to press the injection button firmly, hold it against the skin, wait for the first click, and then continue holding for a further ten seconds before withdrawing, the ten-second hold is part of the standard technique regardless of whether you stop at one click or two, because it ensures the full intended volume is absorbed before the needle is removed.
A few practical details worth knowing: the clicks are audible but not always obvious through thick clothing, so inject through bare skin or thin fabric only. The dose counter window on the pen shows a number moving; for a half dose instruction, your prescriber will have told you exactly what number or marker to stop at, and that window is your secondary confirmation. If you are uncertain whether the click registered, do not press again, contact your prescriber or pharmacist before the next scheduled dose. The detailed breakdown of Mounjaro half-dose clicks covers the counter mechanics if you want that level of specificity.
One thing that trips people up: the physical click mechanism feels the same whether your pen is 2.5 mg or 10 mg, but the drug volume per click is not the same across all strengths. A half dose of a 5 mg pen is 2.5 mg; a half dose of a 7.5 mg pen is 3.75 mg. These are not interchangeable, and the clinical reason for a half dose at 5 mg (usually settling gastrointestinal side effects during an early titration step) is different from a half dose that might occasionally be directed at a higher strength. This is why a prescriber must be in the loop before you change how you use any pen. You can read more about the 5 mg Mounjaro pen specifically if that is the strength you are working with, or the standard Mounjaro dosing schedule for context on where a half dose might fit in a titration plan.
The licensed titration schedule for Mounjaro starts at 2.5 mg, moving through 5 mg, 7.5 mg, 10 mg, 12.5 mg and up to 15 mg in steps the prescriber controls. A half dose sits outside the published schedule; it is a clinical tool for managing the transition, not a long-term mode of treatment. The BNF entry for tirzepatide confirms the licensed dose increments, nothing in the SmPC describes a formal half-dose regimen, which is why the direction has to come from your prescriber in writing or via your aftercare contact.
Stopping partway through an injection is stressful. If you pressed the button and cannot tell whether one or two clicks occurred, the safest step is to withdraw the needle using standard technique (the ten-second wait first), dispose of the pen safely in a sharps container, and contact your prescriber or pharmacy aftercare team before your next dose. Do not try to estimate and administer a second injection to compensate, that is precisely the kind of decision that needs clinical input.
For the days around a half-dose period, keeping a brief injection log helps: note the date, the pen strength, which click you stopped at, and any side effects. That information is genuinely useful if your prescriber reviews your tolerability picture and considers moving you to the next full dose. If you are weighing up where your current dose puts you in the broader treatment journey, the Mounjaro overview sets out how the medicine works across the full schedule. And if you have broader questions about the cost of treatment or what a private prescription covers, the Mounjaro pricing guide answers those without the jargon.
One last point: clicking the pen correctly is only part of the technique. Rotate your injection sites (abdomen, thigh and upper arm are all suitable) and change the needle before each injection. Reusing needles blunts the tip, makes injections more uncomfortable, and increases the risk of injection-site reactions. The guide to half-dosing Mounjaro goes further on the preparation steps if you want a full walkthrough.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.